Back

COVID Seq as Laboratory Developed Test (LDT) for diagnosis of SARS-CoV-2 Variants of Concern (VOC)

2022-11-14 genetic and genomic medicine Title + abstract only
View on medRxiv
Show abstract

Rapid classification and detection of SARS-CoV-2 variants have been critical in comprehending the viruss transmission dynamics. Clinical manifestation of the infection is influenced by comorbidities such as age, immune status, diabetes, and the infecting variant. Thus, clinical management may differ for new variants. For example, some monoclonal antibody treatments are variant-specific. Yet, an FDA-approved test for detecting the SARS-CoV-2 variant is unavailable. A laboratory-developed test (LD...

Predicted journal destinations